Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05260268 · ClinicalTrials.gov registry record · NA
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
A NA study of Cirrhosis and Medication Adherence, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 3
- Study locations
NCT05260268 is a NA study of Cirrhosis and Medication Adherence that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 360 participants, below the 90,402-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05260268, a NA study of Cirrhosis and Medication Adherence, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 3
- Study locations
Study Summary
Liver transplantation is increasingly performed for older adults with multiple comorbidities. Medication adherence is key to maintaining proper function of the transplanted liver and optimize health; however, adhering to post-transplant treatment is complex. This trial will study how available technology combined with transplant center resources and caregiver support can optimize medication adherence, quality of life, and health outcomes among new liver transplant recipients at 3 centers.
Conditions Studied
Interventions
- BEHAVIORAL TEST Intervention
Study Locations (3)
Florida
- University of Miami - Miami
Illinois
- Northwestern University - Chicago
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05260268
The ClinicalTrials.gov registry entry for NCT05260268 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90,402-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which TEST Intervention is the first listed.
NCT05260268 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Illinois, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05260268 about?
NCT05260268 is a clinical study titled "Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant". Liver transplantation is increasingly performed for older adults with multiple comorbidities. Medication adherence is key to maintaining proper function of the transplanted liver and optimize health; however, adhering to post-transplant treatment is complex. This trial will study how available techn...
What is the current status of trial NCT05260268?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2022-12-01. Estimated completion is 2027-01-01.
What conditions does trial NCT05260268 study?
This clinical trial studies the following conditions: Cirrhosis, Medication Adherence, End Stage Liver DIsease, Liver Transplant, Complications.
What interventions are being tested in trial NCT05260268?
The interventions under investigation include: TEST Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05260268?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05260268 being conducted?
This trial has 3 study locations across Florida, Illinois, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Copper Supplementation in Cirrhosis
RECRUITING · NA
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
CirrhosisRx CDS System
RECRUITING · NA
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.